Veliparib

DB07232InvestigationalSmall molecule

Veliparib: Overview.

Mechanism: Pharmacologically active on Poly [ADP-ribose] polymerases
Curator reviewed
Formula / weight: C₁₃H₁₆N₄O · 244.2923 g/mol (avg)
Code names: ABT-888

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyJNAHVYVRKWKWKQ-CYBMUJFWSA-NSMILESC[C@@]1(CCCN1)C1=NC2=CC=CC(C(N)=O)=C2N1

Targets

What you can answer from here — as of June 15, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

39Drug interactionsStructured to mechanism, not free text

99Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 6 drug categories

11+ReferencesStructured and connected to the statements they support

Which drugs share a target with Veliparib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.